Thailand FDA Medical Device Database Analysis: 43,337 Records
A comprehensive analysis of 43,337 medical device records in the Thailand FDA database, exploring active vs expired licenses, imported share, and top manufacturers.
Executive Summary & Direct Answer
For medical device manufacturers targeting the Southeast Asian market, Thailand represents a critical commercial hub. However, navigating the regulatory environment of the Thai Food and Drug Administration (FDA) requires a clear understanding of the actual registration landscape. To provide compliance and market-intelligence professionals with concrete, data-backed insights, this analysis examines the aggregate data from the official Thailand FDA medical device registry.
Based on a detailed extraction and analysis of the 43,337 medical device records registered in the Thai FDA public e-service database, several key trends emerge:
- Imports Dominate the Market: Imported medical devices represent 71.41% (30,949 devices) of all registrations, whereas domestic products account for only 28.59% (12,388 devices).
- High Ratio of Expired Registrations: A surprising 55.04% (23,854 entries) of the registrations in the database are currently expired (หมดอายุ), while only 41.87% (18,147 entries) remain active (คงอยู่). The remaining entries are cancelled (ยกเลิก), cannot be produced/imported (ไม่สามารถผลิตหรือนำเข้าได้), or were not renewed (ไม่ต่ออายุ).
- China Leads Exporters: Among foreign manufacturing origins, the People's Republic of China is the leading exporter with 9,398 registrations, followed by the United States of America with 7,614 registrations. Other major European and Asian exporters such as Germany and Japan follow with 2,736 and 1,782 registrations respectively.
- Concentrated Licensee Landscape: Distribution and regulatory representation in Thailand are heavily concentrated. The top local licensee by volume is Surgix Surgical Co., Ltd. (บริษัท เซอร์จีกซ์ เซอร์จิเคิล จำกัด) with 1,631 registered medical devices, followed by Cook Medical (Thailand) Co., Ltd. (บริษัท คุ้ก เมดิคอล (ประเทศไทย)จำกัด) with 1,042.
This post breaks down these statistics to help manufacturers benchmark their competitors, select local representative partners, and understand regulatory renewal cycles.
Methodology note: The Thai FDA public search portal does not expose a single "browse all" list, so the 43,337 records analyzed here were assembled by querying the portal across a broad set of medical-device terms (e.g. catheter, syringe, implant, ultrasound and their Thai-language equivalents). The result is a large and representative sample of the registry rather than a confirmed exhaustive national total, and it over-samples COVID-era test kits and reagents. Absolute counts describe this sample; the proportional splits (import share, status mix, country mix, licensee concentration) are the more reliable takeaways.
What is the Breakdown of Active vs. Expired Medical Device Registrations in Thailand?
Understanding the status of registrations in the Thai FDA database is critical for competitive intelligence. In many jurisdictions, registries contain thousands of legacy, inactive, or un-renewed records that skew market share calculations if not filtered correctly.
Our analysis of the 43,337 records in the registry shows the following distribution of registration statuses:
| Status (Thai) | Status (English Translation) | Number of Registrations | Percentage of Total Registry |
|---|---|---|---|
| หมดอายุ | Expired | 23,854 | 55.04% |
| คงอยู่ | Active / Outstanding | 18,147 | 41.87% |
| ไม่สามารถผลิตหรือนำเข้าได้ | Suspended / Cannot Produce or Import | 707 | 1.63% |
| ยกเลิก | Cancelled | 615 | 1.42% |
| ไม่ต่ออายุ | Not Renewed | 14 | 0.03% |
| Total | 43,337 | 100.00% |
Explaining the High Expiry Rate
A key regulatory finding is that more than half (55.04%) of the medical device records in the public search database are expired. This high volume of inactive records is primarily due to historical shifts in the Thai regulatory framework under the Medical Device Act B.E. 2551 (2008) and its subsequent amendments:
- Transition to ASEAN MDD Alignment: In 2021, Thailand fully implemented its alignment with the ASEAN Medical Device Directive (AMDD), shifting from a three-tiered system to a modernized four-class risk system. During this transition, legacy registrations had to be re-registered or allowed to expire. Many overseas manufacturers chose not to renew obsolete product lines or opted to consolidate their offerings.
- License Holder Dynamics: In Thailand, the local importer or distributor acts as the license holder. If the commercial relationship between an overseas manufacturer and their local distributor ends, the license is frequently left to expire because it cannot be easily transferred without the original holder's consent. This highlights the value of using an independent third-party license holder, as discussed in our Thailand license holder pricing guide.
- Strict Renewal Timelines: Thai FDA registrations are typically valid for a fixed duration. Failure to submit a renewal application (การต่ออายุใบอนุญาต) before the expiration date results in an automatic change in status to "Expired." Navigating these deadlines requires systematic tracking by local regulatory representatives.
How Do Imports Compare to Domestic Medical Device Manufacturing in Thailand?
Thailand's medical device market is structurally dependent on imports, particularly for high-tech, diagnostic, and implantable systems. The database statistics clearly illustrate this import-reliance:
- Imported Devices (นำเข้า): 30,949 registrations (71.41%)
- Domestic Devices (ผลิต): 12,388 registrations (28.59%)
graph TD
A[Total Registrations: 43,337] --> B[Imported: 30,949 - 71.41%]
A --> C[Domestic: 12,388 - 28.59%]
B --> D[Active: 7,231]
B --> E[Expired/Inactive: 23,718]
C --> F[Active: 10,916]
C --> G[Expired/Inactive: 1,472]
(Note: The above diagram illustrates the breakdown of imported vs. domestic devices and their corresponding activity statuses.)
A notable pattern emerges when activity status is split by origin: domestic registrations are overwhelmingly active (10,916 of 12,388, or 88.1%), whereas imported registrations are mostly expired (23,718 of 30,949, or 76.6%). This is consistent with a large cohort of legacy imported listings (notably COVID-era test kits and reagents) that were registered during the pandemic and later lapsed, while domestically produced devices — mostly ongoing commodity consumables such as gloves, syringes, and gauze — are continuously renewed.
Analyzing the Domestic Manufacturing Sector
While domestic products represent nearly 29% of the registry, their clinical and commercial scope is significantly narrower than that of imports. Domestic manufacturing in Thailand is highly concentrated in:
- Single-use medical disposables (such as surgical gloves, syringes, and IV administration sets)
- Medical textiles, surgical gowns, and face masks
- Basic hospital furniture (hospital beds, examination tables) and orthopedic aids
- Low-risk Class 1 consumables
Thailand is one of the world's largest producers of natural rubber latex, which historically made the country a global export powerhouse for medical gloves. However, for high-value segments—such as active implantable devices, magnetic resonance imaging (MRI) machines, robotic surgical assistants, and advanced molecular diagnostics—the domestic market relies almost exclusively on imported technology.
For overseas manufacturers, this means that while domestic competition is fierce in the commodity consumables sector, the market remains wide open for specialized, high-risk devices. To successfully access this import market, companies must align their regulatory filings with the Thailand FDA registration guide.
Which Foreign Countries Lead the Thai Medical Device Registry?
The country-of-origin data in the Thai FDA database reveals a shifting supply chain landscape. While Western nations historically dominated the imported medical device sector, Asian manufacturers have made substantial gains, particularly in cost-sensitive clinical categories.
Among the 31,012 records that declare a country of origin, the top exporting countries are:
| Rank | Country of Origin (Registry Field) | Number of Registrations | Share of Declared-Origin Records |
|---|---|---|---|
| 1 | People's Republic of China | 9,398 | 30.30% |
| 2 | United States of America | 7,614 | 24.55% |
| 3 | Federal Republic of Germany | 2,736 | 8.82% |
| 4 | Japan | 1,782 | 5.75% |
| 5 | All Other Declared Origins | 9,482 | 30.58% |
| Total | Records With a Declared Origin | 31,012 | 100.00% |
(Note: 12,325 records (28.4%) — almost all domestically produced — leave the country-of-origin field blank, so they are excluded from this export-ranking view.)
The Rise of Chinese Manufacturers
The fact that China has surpassed the United States in total registrations (9,398 vs. 7,614) is a significant commercial indicator. This trend reflects several factors:
- Cost-Competitive Alternatives: Public healthcare networks in Thailand, operating under the Universal Coverage Scheme (UCS), are under constant pressure to control costs. Chinese manufacturers offer Class 2 and Class 3 devices—such as imaging monitors, ultrasound transducers, and surgical instruments—at price points that appeal to cost-conscious public hospital procurement boards.
- Regulatory Efficiency: Chinese medtech companies have aggressively established local subsidiaries or exclusive distribution networks in Thailand, accelerating their submission volumes through the Thai FDA's electronic e-Submission system.
- Broad Product Catalogs: Many Chinese entries represent large volumes of Class 1 and Class 2 consumables, which inflate registration counts relative to high-value, lower-volume Class 4 devices (such as pacemakers or orthopedic implants) where the US and Germany still maintain technical dominance.
Exporters from the United States and Europe must emphasize their clinical evidence, long-term safety records, and total cost of ownership (TCO) when competing in this cost-sensitive market.
Analysis of Local Licensees: Who Holds the Keys to the Market?
In Thailand, medical device registrations are not issued directly to overseas manufacturers. Instead, they are issued to a local Thai entity—either a local subsidiary, a commercial distributor, or an independent regulatory representative. This entity is designated as the Licensee (ผู้รับอนุญาต).
Our analysis of the database reveals that a small number of local companies hold a disproportionate share of the registrations, indicating a highly consolidated commercial distribution landscape. The top 5 licensees by registration volume are:
- Surgix Surgical Co., Ltd. (บริษัท เซอร์จีกซ์ เซอร์จิเคิล จำกัด) — 1,631 registrations
- Focus: Specializes in surgical instruments, orthopedic implants, and operating room consumables. Their high volume reflects extensive catalogs of surgical tools and hardware components.
- Cook Medical (Thailand) Co., Ltd. (บริษัท คุ้ก เมดิคอล (ประเทศไทย)จำกัด) — 1,042 registrations
- Focus: The local subsidiary of the US-based multinational. They maintain direct regulatory control over their diverse cardiovascular, urology, and endoscopy portfolios.
- Hoya Lens Thailand Co., Ltd. (บริษัท โฮยาเลนซ์ ไทยแลนด์ จำกัด) — 972 registrations
- Focus: Ophthalmic medical devices, specifically intraocular lenses (IOLs) and contact lenses.
- Matsunaga (Thailand) Co., Ltd. (บริษัท มัตซึนากะ (ประเทศไทย) จำกัด) — 950 registrations
- Focus: Rehabilitation equipment, wheelchairs, and physical therapy devices.
- Novamedic Co., Ltd. (บริษัท โนวาเมดิค จำกัด) — 895 registrations
- Focus: Local manufacturing and distribution of medical disposables, anesthesiology products, and respiratory therapy devices.
Commercial Risks of Distributor-Held Licenses
For foreign manufacturers, the distribution of licensees highlights a major strategic risk: channel lock-in. If you appoint a local commercial distributor to manage your Thai FDA registrations:
- The distributor legally owns the registration license.
- If the distributor underperforms, you cannot easily transition to a new distributor. Under Thai law, transferring a medical device license requires the active sign-off of the current licensee.
- If the distributor refuses to sign the transfer, you may be forced to re-register the products from scratch, resulting in 6 to 18 months of market disruption and duplicate government fees.
To mitigate this risk, many international firms choose to work with an independent third-party license holder (an Authorized Representative or local service provider) who does not engage in commercial sales. This ensures that the registration remains independent of the sales channel, allowing the manufacturer to switch distributors or appoint multiple dealers without regulatory hurdles.
Regulatory Strategic Implications for Exporters
Based on the quantitative data from the Thai FDA registry, manufacturers should adopt the following strategic actions when planning their market entry or expansion in Thailand:
1. Conduct a Registry Gap Analysis
Before drafting a regulatory submission, search the public Thai FDA search portal to analyze your competitors' active registrations. Determine:
- How many active registrations exist for your specific product category.
- Which local importers are holding licenses for similar product codes.
- Whether competitor licenses are nearing their expiration dates, indicating potential market transitions.
2. Formulate a Multi-Year Renewal Plan
Given that 55.04% of the database is expired, maintaining active status requires proactive lifecycle management. Establish a regulatory calendar that schedules renewal filings at least 180 days prior to the license expiration date. Under current Thai FDA regulations, if a renewal is submitted before the license expires, the importer can continue importing the device while the application is under review. If it lapses by even a single day, shipments will be blocked at customs, and a completely new registration must be initiated.
3. Leverage the Class 1 Auto-Approval Pathway
In January 2025, the Thai FDA introduced an automated approval pathway for Class 1 (low-risk) medical devices. For simple accessories or consumables, this digital pathway reduces approval times to a matter of days. If your product portfolio includes both high-risk systems and low-risk accessories, split the filings to get the accessories approved rapidly through the auto-approval system, while managing the Class 2-4 CSDT (Common Submission Dossier Template) reviews concurrently.
4. Separate Regulatory Ownership from Commercial Sales
Do not default to letting your primary commercial distributor hold your license. Consider using a neutral, professional regulatory representative. This maintains your flexibility to appoint separate distributors for public tenders, private hospital networks, and regional clinics, without having to partition or transfer your regulatory asset.
Thai Filing Classes at a Glance: Matching Your Device to a Pathway
The registry's import dominance and high expiry rate are best understood alongside the four-class filing model that the Thai FDA has enforced since its 2021 alignment with the ASEAN Medical Device Directive. Each class follows a distinct pathway, documentation burden, and review depth — which helps explain why low-risk consumable categories are over-represented in the registration counts.
| Risk Class | Pathway | Typical Examples | Core Documentation | Relative Review Depth |
|---|---|---|---|---|
| Class 1 (low) | Listing | Bandages, basic instruments, non-invasive accessories | Labeling, IFU, Declaration of Conformity, Letter of Authorization | Lightest; qualifying devices can use the January 2025 auto-approval route |
| Class 2 (low-moderate) | Notification | Some IVDs, low-risk electromechanical devices | CSDT dossier, ISO 13485 evidence | Moderate |
| Class 3 (moderate-high) | Notification | Surgical implants, diagnostic imaging accessories | Full CSDT, clinical evidence, risk analysis | Substantial |
| Class 4 (high) | Licensing | Active implants, pacemakers, life-sustaining devices | Full CSDT, clinical data, benefit-risk analysis | Most rigorous |
Because Class 1 and Class 2 consumables (gloves, syringes, tubing, basic IVDs) make up the bulk of the 12,388 domestic registrations and a large share of imports, raw registration counts tend to reward companies with broad consumable catalogs — such as the leading Chinese exporters — rather than specialists in high-value Class 4 systems. When benchmarking competitors, filter the registry by your device's class and intended use rather than comparing total registration volumes.
How Concentrated Is the Licensee Market?
The top five local licensees alone — Surgix Surgical (1,631), Cook Medical Thailand (1,042), Hoya Lens Thailand (972), Matsunaga Thailand (950), and Novamedic (895) — hold 5,490 registrations, or roughly 12.7% of the entire registry. Extending to the top ten pushes that share above 18%. For a database with tens of thousands of records, this indicates a moderately consolidated distribution layer: a handful of well-established importers and manufacturers control a disproportionate share of product listings, while a long tail of smaller licensees handles the remainder. New entrants evaluating partners should weigh a large licensee's catalog breadth and renewal discipline against the bargaining power such concentration gives incumbents.
Frequently Asked Questions (FAQ)
How many active registrations are there currently in the Thai FDA database?
As of June 2026, there are 18,147 active ("คงอยู่") registrations for medical devices in the Thai FDA registry, representing 41.87% of the total 43,337 registered records. The majority of the database records (55.04%) are expired.
Which country is the largest exporter of medical devices to Thailand according to FDA data?
According to registration records, the People's Republic of China is the leading exporter with 9,398 registrations, representing 30.30% of all imported device records. The United States is second with 7,614 registrations (24.55%).
How long is a Thai FDA medical device registration valid?
Under the current regulatory framework, medical device licenses in Thailand are typically valid for 5 years (subject to payment of annual fees and compliance with quality requirements). Renewal applications must be submitted before the expiration date to avoid import disruptions.
Can a foreign manufacturer hold a medical device license in Thailand?
No. The Thai FDA requires the license holder (Licensee) to be a legally registered company resident in Thailand. Foreign manufacturers must appoint a local subsidiary, a distributor, or an independent Authorized Representative to hold the license on their behalf.
How does the Thai FDA Class 1 auto-approval pathway work?
Since January 2025, the Thai FDA has offered an automated approval route for qualifying Class 1 (low-risk) devices. Eligible listings that meet the documentation requirements can be approved within days rather than months, making it attractive for simple accessories and consumables. Higher-risk Class 2–4 devices still proceed through the standard CSDT notification or licensing reviews and cannot use this auto-approval route.
Do registration counts in the Thai FDA database reflect market share?
Not directly. The database counts individual product registrations, not unit sales or revenue, and more than half of the records are expired. A manufacturer with hundreds of active consumable registrations may generate less revenue than a competitor with a handful of high-value Class 4 implant licenses. Use the registry to understand the competitive landscape and licensee structure, not as a proxy for commercial size.
How should I filter the public Thai FDA database for my own market research?
Start from the official Thai FDA search portal and filter by your device type and intended use, then narrow the status field to "คงอยู่" (active) to exclude the large volume of expired records. Note the licensee name for each active competitor registration to map who already holds licenses in your category, and check the country-of-origin field to gauge whether your sourcing geography is already represented. Because the portal caps individual search results, combine several relevant search terms (English and Thai) to build a fuller picture rather than relying on a single query.
Conclusion & Legal Disclaimer
Analyzing the Thailand FDA medical device database reveals a dynamic, import-heavy market where administrative compliance and strategic license ownership are critical success factors. Exporters must look past simple regulatory instructions and design their market-entry structures to protect their intellectual property and distribution flexibility. Three findings should shape that planning: more than half of the public registry is expired, so competitor counts overstate today's active field; China has overtaken the United States in registered device volume, signaling a cost-competitive supply shift that high-value Western manufacturers must answer with clinical evidence and total-cost-of-ownership arguments; and a small group of local licensees controls a disproportionate share of active listings, which makes the choice of — and contractual terms with — your local representative a defining strategic decision rather than an administrative afterthought.
Disclaimer: This analysis is based on public registration data from the Thailand Food and Drug Administration registry as of June 2026. The information provided in this article is for educational and market intelligence purposes only and does not constitute legal, regulatory, or quality-system advice for any specific product or organization. For specific regulatory filings, consult with a qualified regulatory affairs professional or your local representative in Thailand.
Sources
- Thailand FDA Public Search Portal: Food and Drug Administration, Ministry of Public Health, Thailand.
- Medical Device Control Division Announcements: Thai Food and Drug Administration Official Portal.
- Medical Device Act B.E. 2551 (2008) and Amendments: Ministry of Public Health, Government of Thailand.
- ASEAN Medical Device Directive (AMDD): Harmonized regulatory framework for medical devices in the ASEAN region.
- International Trade Administration (ITA) Thailand Country Commercial Guide: U.S. Department of Commerce.